Accuray brings AI in radiotherapy to ESTRO stage focusing on clinical performance and ethics

Accuray brings AI in radiotherapy to ESTRO stage focusing on clinical performance and ethics
Accuray to present AI radiotherapy

Accuray is set to present the integration of artificial intelligence in radiotherapy at the ESTRO event on Monday. The discussion will cover aspects such as clinical performance, the legal framework, and ethical considerations around the use of AI in medical radiation treatments.

Attendees are invited to join the session at 10:15, where industry professionals will examine how AI can improve results and patient care, while also addressing regulatory and ethical challenges in this evolving field.

Accuray recently announced that the National Cancer Center Myanmar used its Radixact system to treat 18 patients in two days following the technology's launch earlier this year. The company also offered limited demo slots for its CyberKnife and helical platforms at the previous ESTRO26 conference, highlighting advancements in radiation therapy at the event. These developments demonstrate Accuray's continued engagement with international clinical partners and industry forums.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.